Company Filing History:
Years Active: 2024-2025
Title: Innovations of Seung Hoon Han in Neurodegenerative Disease Research
Introduction
Seung Hoon Han is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of three patents, Han's work focuses on pharmaceutical compositions and diagnostic methods that aim to improve the understanding and treatment of these debilitating conditions.
Latest Patents
One of Han's latest patents is a pharmaceutical composition for preventing or treating neurodegenerative diseases, which comprises a COX2 acetylating agent as an active ingredient. This invention is particularly noteworthy as it addresses the inhibition of amyloid-β deposition in brain neurons, reduces excessive neuroinflammatory responses, and enhances the phagocytosis of amyloid-β in microglial cells. The composition promotes COX2 acetylation in neurons and secretes specialized pro-resolving mediators (SPMs), making it a promising candidate for the development of preventive or therapeutic agents for neurodegenerative diseases.
Another significant patent by Han is a composition for the diagnosis of degenerative neurological diseases. This invention includes an agent for measuring the level of acetylation of COX2. The reduced acetylation of COX2 in degenerative neurological diseases can serve as a diagnostic marker, allowing for more rapid and accurate diagnosis of these conditions.
Career Highlights
Seung Hoon Han is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation, where he conducts his research. His work has garnered attention for its potential impact on the diagnosis and treatment of neurodegenerative diseases.
Collaborations
Han collaborates with notable colleagues, including Jae-Sung Bae and Hee Kyung Jin, who contribute to his research efforts and innovations in the field.
Conclusion
Seung Hoon Han's innovative work in the realm of neurodegenerative diseases showcases his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of these conditions and offer hope for improved diagnostic and therapeutic strategies.